- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow DR. WERNER KATZMANN Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 242152 [Title] => CAIs: Reaching optimal cholesterol goals [Summary] => A new class of lipid-lowering therapy could make it easier for patients with high cholesterol levels to reach their optimal cholesterol goals.
Such was the good news relayed by Dr. Werner Katzmann, Ph.D., Far East regional medical director of the Schering-Plough Research Institute, in a lecture during the joint annual convention of the Philippine Society of Hypertension and Philippine Lipid Society recently.
[DatePublished] => 2004-03-11 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 239583 [Title] => Lowering LDL-C gets a boost with breakthrough drug [Summary] => A new drug that will reinforce physicians existing therapeutic tools in lowering a patients low-density lipoprotein (LDL-C) or the bad cholesterol, is now out in the market.
Ezetimibe, launched by Schering-Plough Phils. Inc., has been shown to have a clinically significant supplementary effect when used with a statin, reducing LDL-C by an additional 25 percent.
[DatePublished] => 2004-02-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
DR. WERNER KATZMANN
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 242152 [Title] => CAIs: Reaching optimal cholesterol goals [Summary] => A new class of lipid-lowering therapy could make it easier for patients with high cholesterol levels to reach their optimal cholesterol goals.
Such was the good news relayed by Dr. Werner Katzmann, Ph.D., Far East regional medical director of the Schering-Plough Research Institute, in a lecture during the joint annual convention of the Philippine Society of Hypertension and Philippine Lipid Society recently.
[DatePublished] => 2004-03-11 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 239583 [Title] => Lowering LDL-C gets a boost with breakthrough drug [Summary] => A new drug that will reinforce physicians existing therapeutic tools in lowering a patients low-density lipoprotein (LDL-C) or the bad cholesterol, is now out in the market.
Ezetimibe, launched by Schering-Plough Phils. Inc., has been shown to have a clinically significant supplementary effect when used with a statin, reducing LDL-C by an additional 25 percent.
[DatePublished] => 2004-02-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
March 11, 2004 - 12:00am
February 19, 2004 - 12:00am
Recommended
President Ferdinand Marcos Jr. on Monday signed a new law that streamlines tax incentives for businesses in the Philippines, including the taxation of companies in special economic zones.
1 day ago
During the conference, Finance Secretary Ralph Recto emphasized the importance of a business environment that supports consistent progress.
3 days ago
Speaker Martin Romualdez and eight other lawmakers filed House Bill 11034, seeking to move the BARMM parliamentary elections from May 12, 2025 to May 11, 2026.
6 days ago
Lotto Nov 12, 2024
EZ2/LVM - 14 21
SUERTRES - 0 3 2
6D Lotto - 5 3 6 8 3 7
6/42 Lotto - 27 17 29 9 8 32
P9,508,486.00
6/49 Super Lotto - 10 23 3 14 44 8
P122,257,137.00
6/58 Ultra Lotto - 10 22 11 5 38 40
P115,983,208.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66